课题基金 / 基金详情

21-ICRAD Virulent Non-Notifiable Avian Influenza; Determinants of virulence of emerging viruses

21-ICRAD Virulent Non-Notifiable Avian Influenza; Determinants of virulence of emerging viruses
21-ICRAD 不可通报的强毒禽流感;
批准号:
BB/V019899/1
负责人:
Lonneke Vervelde
金额:
$51.66万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --

项目摘要

项目成果

Lonneke Vervelde的其他基金

相似基金

相关文献

中文摘要
翻译
欧洲是世界上最大的禽肉和禽蛋生产国和出口国之一。疾病暴发是对家禽业的主要威胁。禽流感(AI)被列为首要挑战,是欧洲和世界范围内家禽业关注的主要问题。在家禽中,禽流感病毒(AIV)毒株的严重程度分为高致病性(HPAI)和低致病性(LPAI)。高致病性禽流感毒株造成严重感染和高死亡率。H5型和H7型的高致病性禽流感和低致病性禽流感是法定通报疾病,即法律规定必须向政府当局报告的疾病。信息的整理使当局能够监测该疾病,并提供可能爆发的早期预警。欧洲成员国开展监测规划,涉及H5和H7亚型禽流感的疫情应向世界动物卫生组织报告。然而,不仅仅是LPAI H5和H7以及HPAI亚型对家禽业构成威胁。几种非H5/H7亚型,如H3和H9,可具有很强的毒性,感染这些毒株也可造成严重的生产损失。除了经济后果外,这些毒性强、无需通报的低致病性禽流感(n -LPAI)亚型还会造成严重的临床症状、高死亡率,在控制疫情的情况下,还会导致患病和/或健康鸡群被扑杀,从而对动物福利产生重大影响。人工智能是一种人畜共患疾病,过去的流感大流行是由至少部分源自人工智能病毒的病毒引起的。因此,具有高人畜共患潜力的新型低致病性禽流感如果得不到充分控制,可能对公众健康造成巨大影响。fluuance联盟的目标是开发一种诊断工具或鉴定系统,用于毒性的n- lpai菌株。要做到这一点,我们首先必须了解为什么这些通常低致病性的病毒变得更有致病性,以及它们如何与宿主鸡和野生动物的代表:野鸭、鹅和鸽子相互作用。这一知识将使我们能够更好地评估来自动物宿主的病毒对家禽业造成的潜在风险,反之亦然。因此,家禽生产将较少受到这些病毒的威胁,从而减少对动物福利的负面影响并减少被扑杀的禽群数量。如果新出现的新型低致病性禽流感具有很高的人畜共患可能性,则大流行的风险将降低。因此,该提案强调了家禽业日益增长的重要性,并符合消费者对“来自健康动物的健康食品”的要求。
英文摘要
Europe is one of the world's largest poultry meat and egg producers and exporter of poultry products. Disease outbreaks are a major threat for the poultry industry. Avian Influenza (AI) is listed as a top challenge and with that, is a major concern of the European and worldwide poultry industry. In poultry, the severity of AI virus (AIV) strains is classified into Highly Pathogenic (HPAI) or Low Pathogenic (LPAI). HPAI strains cause severe infections and high levels of mortality. HPAI and LPAI of the H5 and H7 types are notifiable diseases, i.e. diseases that are required by law to be reported to government authorities. The collation of information allows the authorities to monitor the disease, and provides early warning of possible outbreaks. European Member states conduct surveillance programmes and outbreaks involving AI H5 and H7 subtypes are notifiable to the OIE. However, not only LPAI H5 and H7 and HPAI subtypes form a threat for the poultry industry. Several of the non H5/H7 subtypes such as H3 and H9, can be very virulent and infections with these strains can also cause severe production losses. Besides the economic consequences, these virulent non-notifiable LPAI (nn-LPAI) subtypes have a major impact on animal welfare by causing severe clinical symptoms, high mortality rates and - in case of controlling the outbreak - culling of diseased and/or healthy flocks. AI is a zoonotic disease and past influenza pandemics were caused by viruses that were at least partly derived from AI viruses. Therefore, impacts on public health may be great if nn-LPAI with high zoonotic potential are not controlled adequately. The FluNuance consortium aims to develop a diagnostic tool or identification system for virulent nn-LPAI strains. To achieve this we will first have to understand why these normally low pathogenic viruses become more pathogenic and how they interact with their hosts, chickens and representatives of wildlife: mallard, geese and pigeon. This knowledge will allow us to better assess the potential risks that viruses from the animal reservoir imposes for the poultry industry and vice versa. As a consequence, poultry production will be threatened less by these viruses, thereby reducing negative impacts on animal welfare and decreasing the numbers of flocks that are culled. In case the emerging nn-LPAI has high zoonotic potential, the risk of a pandemic will be lowered. Thus, this proposal addresses the ever-increasing importance of the poultry industry and aligns with the consumers' demands for 'healthy food from healthy animals'.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the local site and cell types involved in antigen uptake, processing and presentation in the chicken
  • 批准号:
    BB/M003094/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $50.14万
  • 财政年份:
    2015
  • 负责人:
    Lonneke Vervelde
  • 依托单位:
Towards control of Infectious bronchitis virus; understanding cross-protection and the genetic plasticity of IBV
  • 批准号:
    BB/M012069/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $50.93万
  • 财政年份:
    2015
  • 负责人:
    Lonneke Vervelde
  • 依托单位:
海外基金